Mirum Pharmaceuticals Stock Technical Analysis
| MIRM Stock | USD 51.50 1.57 3.14% |
As of the 26th of February, Mirum Pharmaceuticals secures the Downside Deviation of 1.76, mean deviation of 1.74, and Risk Adjusted Performance of 0.1067. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mirum Pharmaceuticals, as well as the relationship between them. Please verify Mirum Pharmaceuticals variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Mirum Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 51.5 per share. Given that Mirum Pharmaceuticals has jensen alpha of 0.2923, we recommend you to check Mirum Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.
Mirum Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mirum, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MirumMirum |
Mirum Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 62.3 | Strong Buy | 10 | Odds |
Most Mirum analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mirum stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mirum Pharmaceuticals, talking to its executives and customers, or listening to Mirum conference calls.
Mirum Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Mirum Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mirum Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Mirum Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Mirum Pharmaceuticals. You can use it to identify possible trend reversals for Mirum Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Mirum Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Mirum Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Mirum Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.17 , which means Mirum Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1040.99, which is the sum of squared deviations for the predicted Mirum Pharmaceuticals price change compared to its average price change.About Mirum Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mirum Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mirum Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mirum Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Mirum Pharmaceuticals. By analyzing Mirum Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mirum Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mirum Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 1.42 | 6.34 | 5.71 | 5.99 | Days Of Inventory On Hand | 164.15 | 173.13 | 199.1 | 230.08 |
Mirum Pharmaceuticals February 26, 2025 Technical Indicators
Most technical analysis of Mirum help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mirum from various momentum indicators to cycle indicators. When you analyze Mirum charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1067 | |||
| Market Risk Adjusted Performance | 0.2471 | |||
| Mean Deviation | 1.74 | |||
| Semi Deviation | 1.58 | |||
| Downside Deviation | 1.76 | |||
| Coefficient Of Variation | 735.65 | |||
| Standard Deviation | 2.27 | |||
| Variance | 5.15 | |||
| Information Ratio | 0.1293 | |||
| Jensen Alpha | 0.2923 | |||
| Total Risk Alpha | 0.2833 | |||
| Sortino Ratio | 0.1672 | |||
| Treynor Ratio | 0.2371 | |||
| Maximum Drawdown | 9.81 | |||
| Value At Risk | (2.86) | |||
| Potential Upside | 4.13 | |||
| Downside Variance | 3.08 | |||
| Semi Variance | 2.51 | |||
| Expected Short fall | (2.15) | |||
| Skewness | 0.7141 | |||
| Kurtosis | 0.8495 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share | Quarterly Revenue Growth 0.894 | Return On Assets | Return On Equity |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.